OPINION - RESECTION OF HEPATIC METASTASIS FOR COLORECTAL-CANCER

被引：0
作者：
NAGORNEY, DM [1 ]
机构：
[1] CARE OF PEMBERTON JH,MAYO CLIN,DEPT SURG,200 1ST ST SW,ROCHESTER,MN 55905
来源：
JOURNAL OF SURGICAL ONCOLOGY | 1991年
关键词：
METASTATIC DISEASE; RETROSPECTIVE ANALYSES; TUMOR FACTORS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [31] Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
    Aparicio, Jorge
    Esposito, Francis
    Serrano, Sara
    Falco, Esther
    Escudero, Pilar
    Ruiz-Casado, Ana
    Manzano, Hermini
    Fernandez-Montes, Ana
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 10
  • [32] Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer
    Krul, Myrtle F.
    Elferink, Marloes A. G.
    Kok, Niels F. M.
    Dekker, Evelien
    Lansdorp-Vogelaar, Iris
    Meijer, Gerrit A.
    Nagtegaal, Iris D.
    Breekveldt, Emilie C. H.
    Ruers, Theo J. M.
    van Leerdam, Monique E.
    Kuhlmann, Koert F. D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03) : 797 - +
  • [33] Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer
    Ghaffari, Abdi
    Hoskin, Victoria
    Turashvili, Gulisa
    Varma, Sonal
    Mewburn, Jeff
    Mullins, Graeme
    Greer, Peter A.
    Kiefer, Friedemann
    Day, Andrew G.
    Madarnas, Yolanda
    SenGupta, Sandip
    Elliott, Bruce E.
    BREAST CANCER RESEARCH, 2019, 21 (1):
  • [34] Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer
    Abdi Ghaffari
    Victoria Hoskin
    Gulisa Turashvili
    Sonal Varma
    Jeff Mewburn
    Graeme Mullins
    Peter A. Greer
    Friedemann Kiefer
    Andrew G. Day
    Yolanda Madarnas
    Sandip SenGupta
    Bruce E. Elliott
    Breast Cancer Research, 21
  • [35] Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer
    A. D. Culverwell
    F. U. Chowdhury
    A. F. Scarsbrook
    Abdominal Imaging, 2012, 37 : 1021 - 1031
  • [36] Response to Chemotherapy in Metastatic Colorectal Cancer After Exposure to Oxaliplatin in the Adjuvant Setting
    Moreau, Louis-Charles
    Rajan, Raghu
    Thirlwell, Michael P.
    Alcindor, Thierry
    ANTICANCER RESEARCH, 2013, 33 (04) : 1765 - 1768
  • [37] Elevated serum E-selectin in patients with liver metastases of colorectal cancer
    Wittig, BM
    Kaulen, H
    Thees, R
    Schmitt, C
    Knolle, P
    Stock, J
    zumBuschenfelde, KHM
    Dippold, W
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) : 1215 - 1218
  • [38] Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer
    Culverwell, A. D.
    Chowdhury, F. U.
    Scarsbrook, A. F.
    ABDOMINAL IMAGING, 2012, 37 (06): : 1021 - 1031
  • [39] Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program
    Salgado Fernandez, Mercedes
    Perez Hoyos, Maria Teresa
    Diaz de Corcuera, Isabela
    Vidal Arbues, Alba
    Garcia de la Torre, Marta
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1171 - 1179
  • [40] Unlocking survival benefits: primary tumor resection in de novo stage IV breast cancer patients
    Chen, Dong
    Wang, Yue
    Pan, Yuancan
    Zhang, Boran
    Yao, Wentao
    Peng, Yu
    Zhang, Ganlin
    Wang, Xiaomin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (12) : 1303 - 1310
12345